226 related articles for article (PubMed ID: 8972457)
1. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids.
Tokumura A; Toujima M; Yoshioka Y; Fukuzawa K
Lipids; 1996 Dec; 31(12):1251-8. PubMed ID: 8972457
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor (PAF)-like phospholipids formed during peroxidation of phosphatidylcholines from different foodstuffs.
Tanaka T; Tokumura A; Tsukatani H
Biosci Biotechnol Biochem; 1995 Aug; 59(8):1389-93. PubMed ID: 7549088
[TBL] [Abstract][Full Text] [Related]
3. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.
Heery JM; Kozak M; Stafforini DM; Jones DA; Zimmerman GA; McIntyre TM; Prescott SM
J Clin Invest; 1995 Nov; 96(5):2322-30. PubMed ID: 7593619
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis.
Tokumura A; Sumida T; Toujima M; Kogure K; Fukuzawa K
Biofactors; 2000; 13(1-4):29-33. PubMed ID: 11237195
[TBL] [Abstract][Full Text] [Related]
5. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
Watson AD; Navab M; Hama SY; Sevanian A; Prescott SM; Stafforini DM; McIntyre TM; Du BN; Fogelman AM; Berliner JA
J Clin Invest; 1995 Feb; 95(2):774-82. PubMed ID: 7860760
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
Liapikos TA; Antonopoulou S; Karabina SP; Tsoukatos DC; Demopoulos CA; Tselepis AD
Biochim Biophys Acta; 1994 Jun; 1212(3):353-60. PubMed ID: 8199206
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines.
Marathe GK; Davies SS; Harrison KA; Silva AR; Murphy RC; Castro-Faria-Neto H; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1999 Oct; 274(40):28395-404. PubMed ID: 10497200
[TBL] [Abstract][Full Text] [Related]
8. Impairment of endothelium-dependent aorta relaxation by phospholipid components of oxidized low-density lipoprotein.
Vasques E; Almeida AL; Noya V; D'Alegria B; Marathe G; McIntyre TM; Tibiriçá E; Bozza PT; Silva AR; Castro-Faria-Neto HC
Endothelium; 2006; 13(1):1-8. PubMed ID: 16885061
[TBL] [Abstract][Full Text] [Related]
9. Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation.
Androulakis N; Durand H; Ninio E; Tsoukatos DC
J Lipid Res; 2005 Sep; 46(9):1923-32. PubMed ID: 15995176
[TBL] [Abstract][Full Text] [Related]
10. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group.
Tanaka T; Iimori M; Tsukatani H; Tokumura A
Biochim Biophys Acta; 1994 Jan; 1210(2):202-8. PubMed ID: 8280771
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
12. Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver.
Marathe GK; Harrison KA; Roberts LJ; Morrow JD; Murphy RC; Tjoelker LW; Prescott SM; Zimmerman GA; McIntyre TM
J Lipid Res; 2001 Apr; 42(4):587-96. PubMed ID: 11290831
[TBL] [Abstract][Full Text] [Related]
13. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
[TBL] [Abstract][Full Text] [Related]
14. Bioactive phospholipid oxidation products.
Marathe GK; Harrison KA; Murphy RC; Prescott SM; Zimmerman GA; McIntyre TM
Free Radic Biol Med; 2000 Jun; 28(12):1762-70. PubMed ID: 10946218
[TBL] [Abstract][Full Text] [Related]
15. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.
Tselepis AD; Dentan C; Karabina SA; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1764-73. PubMed ID: 7583554
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein.
Silva AR; de Assis EF; Caiado LF; Marathe GK; Bozza MT; McIntyre TM; Zimmerman GA; Prescott SM; Bozza PT; Castro-Faria-Neto HC
J Immunol; 2002 Apr; 168(8):4112-20. PubMed ID: 11937571
[TBL] [Abstract][Full Text] [Related]
17. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.
Steinbrecher UP; Pritchard PH
J Lipid Res; 1989 Mar; 30(3):305-15. PubMed ID: 2723538
[TBL] [Abstract][Full Text] [Related]
18. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
Subramanian VS; Goyal J; Miwa M; Sugatami J; Akiyama M; Liu M; Subbaiah PV
Biochim Biophys Acta; 1999 Jul; 1439(1):95-109. PubMed ID: 10395969
[TBL] [Abstract][Full Text] [Related]
19. LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro.
Schnitzer E; Pinchuk I; Fainaru M; Lichtenberg D; Yedgar S
Free Radic Biol Med; 1998 May; 24(7-8):1294-303. PubMed ID: 9626586
[TBL] [Abstract][Full Text] [Related]
20. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
